Stanmax Pharma Pvt Ltd - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 1993.
1993 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Stanmax Pharma Pvt Ltd

Stanmax Pharma Pvt Ltd, a struck off private limited company, was established on 25 June 1993 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24235TG1993PTC015918. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.30 M.

Its leadership includes Ghanukota Rupa (Director), Dasari Sridhar (Director), Nyapathy Raghunandan (Director). It holds no open charges and ₹9.29 M settled loans. Its latest AGM occurred on 27 September 2014, with the balance sheet filed on 31 March 2014. It is based at 2-24-86/3/1,Laxmi Narayana Colony,Ida, Uppal, Hyderabad, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24235TG1993PTC015918

  • Registration Number

    015918

  • Incorporation Date

    25 June 1993

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.30 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.30 M
  • Company Age 32 Year, 10 Months
  • Last Filing with ROC 31 Mar 2014
  • Satisfied Charges ₹ 9.29 M
Company report

Stanmax Pharma Pvt Ltd

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Stanmax Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stanmax Pharma Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Ghanukota Rupa Director 04 Apr 2007 Current
Dasari Sridhar Director 04 Apr 2007 Current
Nyapathy Raghunandan Director 04 Apr 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stanmax Pharma.

Enhance accessibility to Stanmax Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Stanmax Pharma revenue growth over time
Stanmax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stanmax Pharma?

Unlock access to Stanmax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹9,293,000.00

Charges Breakdown by Lending Institutions
  • A.P. State Financial Corporation : 0.93 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2002 A.P. State Financial Corporation ₹9.29 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Stanmax Pharma?

Unlock and access historical data on people associated with Stanmax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stanmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanmax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stanmax Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Stanmax Pharma Pvt Ltd last Annual general meeting of members was held on 27 Sep 2014 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Stanmax Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Ghanukota Rupa was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 19 years 1 month . was completed.

  • Director Appointment

    Dasari Sridhar was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 19 years 1 month . was recorded as a recent event.

  • Director Appointment

    Nyapathy Raghunandan was appointed as a Director was appointed as a Director on 04 Apr 2007 & has been associated with this company since 19 years 1 month . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 13 Aug 2002 via Charge ID 90134582 with A.P. State Financial Corporation was fully satisfied on 04 Jul 2005. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stanmax Pharma Pvt Ltd?

The CIN of Stanmax Pharma Pvt Ltd is U24235TG1993PTC015918.

Where is Stanmax Pharma Pvt Ltd headquartered?

Stanmax Pharma Pvt Ltd is headquartered at 2-24-86/3/1,Laxmi Narayana Colony,Ida, Uppal, Hyderabad, Telangana, 500039.

When was Stanmax Pharma Pvt Ltd incorporated?

Stanmax Pharma Pvt Ltd was incorporated on 25 June 1993.

Who are the current directors of Stanmax Pharma Pvt Ltd?

The current directors of Stanmax Pharma Pvt Ltd are

What is the primary industry of Stanmax Pharma Pvt Ltd?

The primary industry of Stanmax Pharma Pvt Ltd is Chemicals.

Is Stanmax Pharma Pvt Ltd a listed company?

Stanmax Pharma Pvt Ltd is unlisted.

What is the capital structure of Stanmax Pharma Pvt Ltd?

The authorized capital of Stanmax Pharma Pvt Ltd is ₹1.50 M, and the paid-up capital is ₹1.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available